1. Home
  2. WILC vs STRO Comparison

WILC vs STRO Comparison

Compare WILC & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WILC

G. Willi-Food International Ltd.

N/A

Current Price

$33.61

Market Cap

487.6M

ML Signal

N/A

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$26.09

Market Cap

524.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WILC
STRO
Founded
1994
2003
Country
Israel
United States
Employees
N/A
133
Industry
Food Distributors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
487.6M
524.8M
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
WILC
STRO
Price
$33.61
$26.09
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$31.33
AVG Volume (30 Days)
2.5K
305.5K
Earning Date
05-18-2026
05-11-2026
Dividend Yield
2.70%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.45
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.30
$0.67
52 Week High
$37.35
$43.85

Technical Indicators

Market Signals
Indicator
WILC
STRO
Relative Strength Index (RSI) 47.48 40.48
Support Level $33.00 $23.43
Resistance Level $37.13 $27.96
Average True Range (ATR) 1.19 3.16
MACD -0.53 -0.73
Stochastic Oscillator 14.02 17.09

Price Performance

Historical Comparison
WILC
STRO

About WILC G. Willi-Food International Ltd.

G. Willi-Food International Ltd is an Israeli-based company specializing in high-quality, great-tasting kosher food products. The company is engaged, directly and through subsidiaries, in the design, import, marketing and distribution of a variety of over 650 food products. The principal product line includes Canned Vegetables and Pickles, Canned Fish, Canned Fruit, Edible Oils, Dairy and Dairy Substitute Products, Cereals, rice and pastas, and Other Products. The company has one reportable segment: Import- export, marketing and distribution of food products. The majority of the company's revenue is derived from the sale of Dairy and Dairy Substitute Products.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: